627
Participants
Start Date
August 31, 2013
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
E10030
ranibizumab
E10030 sham intravitreal injection
Pressure on the eye with a syringe with no needle
Budapest
Budapest
Budapest
Santa Fe
Sydney
Westmead
Parramatta
Glostrup Municipality
East Melbourne
Malvern
Roskilde
Córdoba
Odense
Nedlands
Ankara
Szeged
Pécs
Aarhus C
Magyarszék
Aalborg
New York
Marseille
Syracuse
Hamburg
Baltimore
Hagerstown
Richmond
Virginia Beach
Lübeck
Kiel
Winston-Salem
Charlotte
Asheville
West Columbia
Greenville
Atlanta
Augusta
Navarro
Haifa
Orlando
Fort Lauderdale
Boynton Beach
Largo
Fort Myers
Las Palmas
Izmir
Izmir
Tours
Göttingen
Nashville
Cleveland
Cleveland
Valencia
Bilbao
Münster
Münster
Petah Tikva
West Des Moines
Cologne
Aachen
Bonn
Mainz
Minneapolis
Rapid City
Harvey
Tel Aviv
Shawnee Mission
Strasbourg
Wichita
Lyon
Heidelberg
Lyon
Tübingen
Oklahoma City
Paris
Paris
Paris
Dallas
Paris
Rouen
Rehovot
Karlsruhe
Houston
San Antonio
San Antonio
McAllen
Austin
Freiburg im Breisgau
Aurora
München
Golden
München
Salt Lake City
Tucson
Tucson
Jerusalem
La Jolla
Loma Linda
Santa Ana
Fresno
Créteil
Mountain View
Sacramento
Bellevue
Bogotá
Kfar Saba
Santiago de Cali
Peabody
Worcester
Lawrenceville
Buenos Aires
Buenos Aires
Buenos Aires
Buenos Aires
Medellín
Leipzig
Budapest
Budapest
Debrecen
Barcelona
Sant Cugat del Vallès
Lead Sponsor
Ophthotech Corporation
INDUSTRY